Pfizer-BioNTech submits new COVID vaccine booster targeting BA.5 to the FDA for authorization

  • 📰 USATODAYhealth
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 51%

United States Headlines News

United States Latest News,United States Headlines

Pfizer and German partner BioNTech have submitted their new COVID-19 booster – that targets the omicron subvariant BA.5 – to the FDA for emergency use authorization.

The CDC is responding to criticism over its handling of the COVID-19 pandemic, monkeypox and other public health threats.Pfizer and German partner BioNTech have submitted their new COVID-19 booster – that targets the omicron subvariant BA.

The company has tested the BA.5-specific vaccine only on mice, so far, and is relying on data from both the BA.1 human trials and the BA.5 mice trials for their submission for authorization. “To rely only on mouse data would be unprecedented in my knowledge and would certainly raise eyebrows,” said John Moore, a vaccine and virology expert at Weill Cornell Medicine in New York. “It doesn’t mimic the human situation,” where many people were vaccinated more than a year ago and have since been boosted.

But Moore isn't convinced the data will show the BA.5 booster working significantly better than the BA.1 booster, or even the original booster. The public expects the new booster to prevent more infections, he said, but it will probably be only marginally more protective.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 706. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer-BioNTech Submits the First Omicron COVID-19 Booster for FDA AuthorizationPfizer-BioNTech Submit the First Omicron COVID-19 Booster for FDA Authorization
Source: TIMEHealth - 🏆 121. / 63 Read more »

Pfizer, BioNTech Seek FDA Authorization for Updated Covid-19 VaccineThe updated shot, which targets the latest Omicron subvariants as well as the original virus, would be used in a fall booster campaign.
Source: WSJhealth - 🏆 413. / 53 Read more »

Pfizer asks FDA to authorize updated COVID vaccine adding protection from Omicron variantsThe FDA ordered vaccine makers to tweak their shots to target BA.4 and BA.5. Pfizer and its partner BioNTech aim to offer updated boosters to people 12 and older, and shots could begin within weeks if the FDA quickly clears the modified vaccine. Let me rephrase for you... The largest criminal organization ever (if you measure by who has paid the highest criminal fines) has asked the least trusted health institution in America to authorize mandated revenue. Journalists these days...
Source: abc7newsbayarea - 🏆 529. / 51 Read more »

Pfizer asks FDA to authorize updated COVID vaccine adding protection from Omicron variantsThe FDA ordered vaccine makers to tweak their shots to target BA.4 and BA.5. Pfizer and its partner BioNTech aim to offer updated boosters to people 12 and older, and shots could begin within weeks if the FDA quickly clears the modified vaccine. Om done with that BS
Source: ABC7Chicago - 🏆 284. / 63 Read more »

Pfizer seeks OK of updated COVID vaccine booster for fallPfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives.
Source: AKNewsNow - 🏆 460. / 53 Read more »

Pfizer seeks OK of updated COVID vaccine booster for fallThe U.S. has a contract to buy 105 million of the updated Pfizer doses as soon as health authorities greenlight them, and the company said doses are ready to ship. Nobody wants them. So why are they buying them? Oh wait, I know.. 💵 Whatever you do, don’t get vaccinated
Source: 13WHAM - 🏆 256. / 63 Read more »